Danish dermatology specialist LEO Pharma today announced that Swissmedic, Switzerland’s national regulatory agency for ...

Anzupgo is the first topical pan-Janus kinase (JAK) inhibitor to be approved in Switzerland specifically for moderate to ...

New psychoactive substances are synthetic substances with narcotic-like effects. They are sold as intoxicants and also called designer drugs. Their consumption is a health risk: it is not known how ...

Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT TrialSAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Travere ...

SAN DIEGO - Travere Therapeutics, Inc. (NASDAQ:TVTX) and CSL (OTC:CSLLY) Vifor announced that Swissmedic, the Swiss regulatory authority, has granted temporary marketing authorization for FILSPARI for ...

"Swissmedic approval further demonstrates our promise to deliver transformational medicines for patients with serious diseases in our areas of focus," said Emmanuelle Lecomte Brisset, Senior Vice ...

ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Swissmedic has granted temporary marketing ...

“Swissmedic approval further demonstrates our promise to deliver transformational medicines for patients with serious diseases in our areas of focus,” said Emmanuelle Lecomte Brisset, senior vice ...

ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Swissmedic has granted temporary marketing ...

Bern, 07.10.2024 - In 2023, Swissmedic conducted medical device inspections in 25 hospitals. The checks again revealed a need for action in all inspected areas, particularly in quality management, ...